Skip to main content
Clinical Trials/NL-OMON29401
NL-OMON29401
Recruiting
Not Applicable

Diabetying & lifestyle as medicine programme for people with diabetes type II in primary care – an implementation pilot

TNO0 sites16 target enrollmentTBD
ConditionsType 2 diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
TNO
Enrollment
16
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

not applicable

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
TNO

Eligibility Criteria

Inclusion Criteria

  • Patient is newly diagnosed with T2D
  • \-Patient is about to start Metformin
  • \-Patient is about to start with a second oral drug (like SU\-derivates)
  • \-Patient is about to start with an injectable drug (Insulin or GLP\-1\)
  • Besides that, the patients should meet the following inclusion criteria:
  • \-Aged between 30\-80 years
  • \-Have a BMI between 25\-35 kg/m\-2
  • \-Willing and able to sign the informed consent form
  • \-Able to fill in the 360\-degree questionnaire which is in Dutch
  • \-Able to work with computers (e.g. for filling out questionnaires).

Exclusion Criteria

  • \-Dialysis patients
  • \-Possible limiting personal circumstances (e.g. unemployed, illness in the family, dept restructuring)
  • \-Patients under treatment of a psychiatrist
  • \-Incapacitated patients
  • \-Patients in a palliative phase

Outcomes

Primary Outcomes

Not specified

Similar Trials